fluoxetine has been researched along with Rett Syndrome in 5 studies
Fluoxetine: The first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional antidepressants.
fluoxetine : A racemate comprising equimolar amounts of (R)- and (S)-fluoxetine. A selective serotonin reuptake inhibitor (SSRI), it is used (generally as the hydrochloride salt) for the treatment of depression (and the depressive phase of bipolar disorder), bullimia nervosa, and obsessive-compulsive disorder.
N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine : An aromatic ether consisting of 4-trifluoromethylphenol in which the hydrogen of the phenolic hydroxy group is replaced by a 3-(methylamino)-1-phenylpropyl group.
Rett Syndrome: An inherited neurological developmental disorder that is associated with X-LINKED INHERITANCE and may be lethal in utero to hemizygous males. The affected female is normal until the age of 6-25 months when progressive loss of voluntary control of hand movements and communication skills; ATAXIA; SEIZURES; autistic behavior; intermittent HYPERVENTILATION; and HYPERAMMONEMIA appear. (From Menkes, Textbook of Child Neurology, 5th ed, p199)
| Excerpt | Relevance | Reference |
|---|---|---|
| " We present a patient whose severe hyperventilation and apneic attacks resolved with the concomitant treatment of fluoxetine and buspirone." | 7.78 | Use of buspirone and fluoxetine for breathing problems in Rett syndrome. ( Ardıç, UA; Gökben, S; Serdaroğlu, G, 2012) |
| " We present a patient whose severe hyperventilation and apneic attacks resolved with the concomitant treatment of fluoxetine and buspirone." | 3.78 | Use of buspirone and fluoxetine for breathing problems in Rett syndrome. ( Ardıç, UA; Gökben, S; Serdaroğlu, G, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 2 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Villani, C | 2 |
| Sacchetti, G | 2 |
| Carli, M | 2 |
| Invernizzi, RW | 2 |
| Castaldo, AM | 1 |
| Temudo, T | 1 |
| Rios, M | 1 |
| Prior, C | 1 |
| Carrilho, I | 1 |
| Santos, M | 1 |
| Maciel, P | 1 |
| Sequeiros, J | 1 |
| Fonseca, M | 1 |
| Monteiro, J | 1 |
| Cabral, P | 1 |
| Vieira, JP | 1 |
| Ormazabal, A | 1 |
| Artuch, R | 1 |
| Pan, CH | 1 |
| Tsai, S | 1 |
| Gökben, S | 1 |
| Ardıç, UA | 1 |
| Serdaroğlu, G | 1 |
1 trial available for fluoxetine and Rett Syndrome
| Article | Year |
|---|---|
Evaluation of CSF neurotransmitters and folate in 25 patients with Rett disorder and effects of treatment.
Topics: Administration, Oral; Child; Child, Preschool; DNA Mutational Analysis; Female; Fluoxetine; Folic Ac | 2009 |
4 other studies available for fluoxetine and Rett Syndrome
| Article | Year |
|---|---|
Fluoxetine rescues rotarod motor deficits in Mecp2 heterozygous mouse model of Rett syndrome via brain serotonin.
Topics: Animals; Brain; Female; Fluoxetine; Male; Methyl-CpG-Binding Protein 2; Mice; Mice, Inbred C57BL; Mi | 2020 |
Fluoxetine increases brain MeCP2 immuno-positive cells in a female Mecp2 heterozygous mouse model of Rett syndrome through endogenous serotonin.
Topics: Animals; Antidepressive Agents; Brain; Disease Models, Animal; Female; Fluoxetine; Heterozygote; Mal | 2021 |
Early intervention with psychostimulants or antidepressants to increase methyl-CpG-binding protein 2 (MeCP2) expressions: a potential therapy for Rett syndrome.
Topics: Antidepressive Agents; Brain-Derived Neurotrophic Factor; Cocaine; Early Medical Intervention; Femal | 2012 |
Use of buspirone and fluoxetine for breathing problems in Rett syndrome.
Topics: Apnea; Buspirone; Child; Female; Fluoxetine; Humans; Hyperventilation; Rett Syndrome; Selective Sero | 2012 |